Royce & Associates LP Theravance Biopharma, Inc. Transaction History
Royce & Associates LP
- $10.3 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding TBPH
# of Institutions
129Shares Held
46.5MCall Options Held
600Put Options Held
300-
Madison Avenue Partners, LP New York, NY9.51MShares$92.4 Million14.29% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$72.5 Million2.02% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$46.2 Million9.1% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$36.7 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$26.8 Million2.79% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $649M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...